Text translation

Detect language
French
Translate from
Detect language
All languages
Afrikaans
Albanian
Amharic
Arabic
Armenian
Assamese
Aymara
Azerbaijani
Bambara
Basque
Belarusian
Bengali
Bhojpuri
Bosnian
Bulgarian
Catalan
Cebuano
Chichewa
Chinese (Simplified)
Chinese (Traditional)
Corsican
Croatian
Czech
Danish
Dhivehi
Dogri
Dutch
English
Esperanto
Estonian
Ewe
Filipino
Finnish
French
Frisian
Galician
Georgian
German
Greek
Guarani
Gujarati
Haitian Creole
Hausa
Hawaiian
Hebrew
Hindi
Hmong
Hungarian
Icelandic
Igbo
Ilocano
Indonesian
Irish
Italian
Japanese
Javanese
Kannada
Kazakh
Khmer
Kinyarwanda
Konkani
Korean
Krio
Kurdish (Kurmanji)
Kurdish (Sorani)
Kyrgyz
Lao
Latin
Latvian
Lingala
Lithuanian
Luganda
Luxembourgish
Macedonian
Maithili
Malagasy
Malay
Malayalam
Maltese
Maori
Marathi
Meiteilon (Manipuri)
Mizo
Mongolian
Myanmar (Burmese)
Nepali
Norwegian
Odia (Oriya)
Oromo
Pashto
Persian
Polish
Portuguese
Punjabi
Quechua
Romanian
Russian
Samoan
Sanskrit
Scots Gaelic
Sepedi
Serbian
Sesotho
Shona
Sindhi
Sinhala
Slovak
Slovenian
Somali
Spanish
Sundanese
Swahili
Swedish
Tajik
Tamil
Tatar
Telugu
Thai
Tigrinya
Tsonga
Turkish
Turkmen
Twi
Ukrainian
Urdu
Uyghur
Uzbek
Vietnamese
Welsh
Xhosa
Yiddish
Yoruba
Zulu
Translate to
All languages
Afrikaans
Albanian
Amharic
Arabic
Armenian
Assamese
Aymara
Azerbaijani
Bambara
Basque
Belarusian
Bengali
Bhojpuri
Bosnian
Bulgarian
Catalan
Cebuano
Chichewa
Chinese (Simplified)
Chinese (Traditional)
Corsican
Croatian
Czech
Danish
Dhivehi
Dogri
Dutch
English
Esperanto
Estonian
Ewe
Filipino
Finnish
French
Frisian
Galician
Georgian
German
Greek
Guarani
Gujarati
Haitian Creole
Hausa
Hawaiian
Hebrew
Hindi
Hmong
Hungarian
Icelandic
Igbo
Ilocano
Indonesian
Irish
Italian
Japanese
Javanese
Kannada
Kazakh
Khmer
Kinyarwanda
Konkani
Korean
Krio
Kurdish (Kurmanji)
Kurdish (Sorani)
Kyrgyz
Lao
Latin
Latvian
Lingala
Lithuanian
Luganda
Luxembourgish
Macedonian
Maithili
Malagasy
Malay
Malayalam
Maltese
Maori
Marathi
Meiteilon (Manipuri)
Mizo
Mongolian
Myanmar (Burmese)
Nepali
Norwegian
Odia (Oriya)
Oromo
Pashto
Persian
Polish
Portuguese
Punjabi
Quechua
Romanian
Russian
Samoan
Sanskrit
Scots Gaelic
Sepedi
Serbian
Sesotho
Shona
Sindhi
Sinhala
Slovak
Slovenian
Somali
Spanish
Sundanese
Swahili
Swedish
Tajik
Tamil
Tatar
Telugu
Thai
Tigrinya
Tsonga
Turkish
Turkmen
Twi
Ukrainian
Urdu
Uyghur
Uzbek
Vietnamese
Welsh
Xhosa
Yiddish
Yoruba
Zulu
Getting translation...

Source text

BACKGROUND: Although delirium is typically an acute reversible cognitive impairment, its presence is associated with devastating impact on both short-term and long-term outcomes for critically ill patients. Advances in our understanding of the negative impact of delirium on patient outcomes have prompted trials evaluating multiple pharmacological interventions. However, considerable uncertainty surrounds the relative benefits and safety of available pharmacological interventions for this population. OBJECTIVES: Primary objective1. To assess the effects of pharmacological interventions for treatment of delirium on duration of delirium in critically ill adults with confirmed or documented high risk of deliriumSecondary objectivesTo assess the following:1. effects of pharmacological interventions on delirium-free and coma-free days; days with coma; delirium relapse; duration of mechanical ventilation; intensive care unit (ICU) and hospital length of stay; mortality; and long-term outcomes (e.g. cognitive; discharge disposition; health-related quality of life); and2. the safety of such treatments for critically ill adult patients. SEARCH METHODS: We searched the following databases from their inception date to 21 March 2019: Ovid MEDLINE®, Ovid MEDLINE® In-Process & Other Non-Indexed Citations, Embase Classic+Embase, and PsycINFO using the Ovid platform. We also searched the Cochrane Library on Wiley, the International Prospective Register of Systematic Reviews (PROSPERO) (http://www.crd.york.ac.uk/PROSPERO/), the Cumulative Index to Nursing and Allied Health Literature (CINAHL), and Web of Science. We performed a grey literature search of relevant databases and websites using the resources listed in Grey Matters developed by the Canadian Agency for Drugs and Technologies in Health (CADTH). We also searched trial registries and abstracts from annual scientific critical care and delirium society meetings. SELECTION CRITERIA: We sought randomized controlled trials (RCTs), including quasi-RCTs, of any pharmacological (drug) for treatment of delirium in critically ill adults. The drug intervention was to be compared to another active drug treatment, placebo, or a non-pharmacological intervention (e.g. mobilization). We did not apply any restrictions in terms of drug class, dose, route of administration, or duration of delirium or drug exposure. We defined critically ill patients as those treated in an ICU of any specialty (e.g. burn, cardiac, medical, surgical, trauma) or high-dependency unit. DATA COLLECTION AND ANALYSIS: Two review authors independently identified studies from the search results; four review authors (in pairs) performed data extraction and assessed risk of bias independently. We performed data synthesis through pairwise meta-analysis and network meta-analysis (NMA). Our hypothetical network structure was designed to be analysed at the drug class level and illustrated a network diagram of 'nodes' (i.e. drug classes) and 'edges' (i.e. comparisons between different drug classes from existing trials), thus describing a treatment network of all possible comparisons between drug classes. We assessed the quality of the body of evidence according to GRADE, as very low, low, moderate, or high. MAIN RESULTS: We screened 7674 citations, from which 14 trials with 1844 participants met our inclusion criteria. Ten RCTs were placebo-controlled, and four reported comparisons of different drugs. Drugs examined in these trials were the following: antipsychotics (n = 10), alpha(2) agonists (n = 3; all dexmedetomidine), statins (n = 2), opioids (n = 1; morphine), serotonin antagonists (n = 1; ondansetron), and cholinesterase (CHE) inhibitors (n = 1; rivastigmine). Only one of these trials consistently used non-pharmacological interventions that are known to improve patient outcomes in both intervention and control groups.Eleven studies (n = 1153 participants) contributed to analysis of the primary outcome. Results of the NMA showed that the intervention with the smallest ratio of means (RoM) (i.e. most preferred) compared with placebo was the alpha(2) agonist dexmedetomidine (0.58; 95% credible interval (CrI) 0.26 to 1.27; surface under the cumulative ranking curve (SUCRA) 0.895; moderate-quality evidence). In order of descending SUCRA values (best to worst), the next best interventions were atypical antipsychotics (RoM 0.80, 95% CrI 0.50 to 1.11; SUCRA 0.738; moderate-quality evidence), opioids (RoM 0.88, 95% CrI 0.37 to 2.01; SUCRA 0.578; very-low quality evidence), and typical antipsychotics (RoM 0.96, 95% CrI 0.64 to1.36; SUCRA 0.468; high-quality evidence).The NMAs of multiple secondary outcomes revealed that only the alpha(2) agonist dexmedetomidine was associated with a shorter duration of mechanical ventilation (RoM 0.55, 95% CrI 0.34 to 0.89; moderate-quality evidence), and the CHE inhibitor rivastigmine was associated with a longer ICU stay (RoM 2.19, 95% CrI 1.47 to 3.27; moderate-quality evidence). Adverse events often were not reported in these trials or, when reported, were rare; pair-wise analysis of QTc prolongation in seven studies did not show significant differences between antipsychotics, ondansetron, dexmedetomidine, and placebo. AUTHORS' CONCLUSIONS: We identified trials of varying quality that examined six different drug classes for treatment of delirium in critically ill adults. We found evidence that the alpha(2) agonist dexmedetomidine may shorten delirium duration, although this small effect (compared with placebo) was seen in pairwise analyses based on a single study and was not seen in the NMA results. Alpha(2) agonists also ranked best for duration of mechanical ventilation and length of ICU stay, whereas the CHE inhibitor rivastigmine was associated with longer ICU stay. We found no evidence of a difference between placebo and any drug in terms of delirium-free and coma-free days, days with coma, physical restraint use, length of stay, long-term cognitive outcomes, or mortality. No studies reported delirium relapse, resolution of symptoms, or quality of life. The ten ongoing studies and the six studies awaiting classification that we identified, once published and assessed, may alter the conclusions of the review.
BACKGROUND: Although delirium is typically an acute reversible cognitive impairment, its presence is associated with devastating impact on both short-term and long-term outcomes for critically ill patients. Advances in our understanding of the negative impact of delirium on patient outcomes have prompted trials evaluating multiple pharmacological interventions. However, considerable uncertainty surrounds the relative benefits and safety of available pharmacological interventions for this population. OBJECTIVES: Primary objective1. To assess the effects of pharmacological interventions for treatment of delirium on duration of delirium in critically ill adults with confirmed or documented high risk of deliriumSecondary objectivesTo assess the following:1. effects of pharmacological interventions on delirium-free and coma-free days; days with coma; delirium relapse; duration of mechanical ventilation; intensive care unit (ICU) and hospital length of stay; mortality; and long-term outcomes (e.g. cognitive; discharge disposition; health-related quality of life); and2. the safety of such treatments for critically ill adult patients. SEARCH METHODS: We searched the following databases from their inception date to 21 March 2019: Ovid MEDLINE®, Ovid MEDLINE® In-Process & Other Non-Indexed Citations, Embase Classic+Embase, and PsycINFO using the Ovid platform. We also searched the Cochrane Library on Wiley, the International Prospective Register of Systematic Reviews (PROSPERO) (http://www.crd.york.ac.uk/PROSPERO/), the Cumulative Index to Nursing and Allied Health Literature (CINAHL), and Web of Science. We performed a grey literature search of relevant databases and websites using the resources listed in Grey Matters developed by the Canadian Agency for Drugs and Technologies in Health (CADTH). We also searched trial registries and abstracts from annual scientific critical care and delirium society meetings. SELECTION CRITERIA: We sought randomized controlled trials (RCTs), including quasi-RCTs, of any pharmacological (drug) for treatment of delirium in critically ill adults. The drug intervention was to be compared to another active drug treatment, placebo, or a non-pharmacological intervention (e.g. mobilization). We did not apply any restrictions in terms of drug class, dose, route of administration, or duration of delirium or drug exposure. We defined critically ill patients as those treated in an ICU of any specialty (e.g. burn, cardiac, medical, surgical, trauma) or high-dependency unit. DATA COLLECTION AND ANALYSIS: Two review authors independently identified studies from the search results; four review authors (in pairs) performed data extraction and assessed risk of bias independently. We performed data synthesis through pairwise meta-analysis and network meta-analysis (NMA). Our hypothetical network structure was designed to be analysed at the drug class level and illustrated a network diagram of 'nodes' (i.e. drug classes) and 'edges' (i.e. comparisons between different drug classes from existing trials), thus describing a treatment network of all possible comparisons between drug classes. We assessed the quality of the body of evidence according to GRADE, as very low, low, moderate, or high. MAIN RESULTS: We screened 7674 citations, from which 14 trials with 1844 participants met our inclusion criteria. Ten RCTs were placebo-controlled, and four reported comparisons of different drugs. Drugs examined in these trials were the following: antipsychotics (n = 10), alpha(2) agonists (n = 3; all dexmedetomidine), statins (n = 2), opioids (n = 1; morphine), serotonin antagonists (n = 1; ondansetron), and cholinesterase (CHE) inhibitors (n = 1; rivastigmine). Only one of these trials consistently used non-pharmacological interventions that are known to improve patient outcomes in both intervention and control groups.Eleven studies (n = 1153 participants) contributed to analysis of the primary outcome. Results of the NMA showed that the intervention with the smallest ratio of means (RoM) (i.e. most preferred) compared with placebo was the alpha(2) agonist dexmedetomidine (0.58; 95% credible interval (CrI) 0.26 to 1.27; surface under the cumulative ranking curve (SUCRA) 0.895; moderate-quality evidence). In order of descending SUCRA values (best to worst), the next best interventions were atypical antipsychotics (RoM 0.80, 95% CrI 0.50 to 1.11; SUCRA 0.738; moderate-quality evidence), opioids (RoM 0.88, 95% CrI 0.37 to 2.01; SUCRA 0.578; very-low quality evidence), and typical antipsychotics (RoM 0.96, 95% CrI 0.64 to1.36; SUCRA 0.468; high-quality evidence).The NMAs of multiple secondary outcomes revealed that only the alpha(2) agonist dexmedetomidine was associated with a shorter duration of mechanical ventilation (RoM 0.55, 95% CrI 0.34 to 0.89; moderate-quality evidence), and the CHE inhibitor rivastigmine was associated with a longer ICU stay (RoM 2.19, 95% CrI 1.47 to 3.27; moderate-quality evidence). Adverse events often were not reported in these trials or, when reported, were rare; pair-wise analysis of QTc prolongation in seven studies did not show significant differences between antipsychotics, ondansetron, dexmedetomidine, and placebo. AUTHORS' CONCLUSIONS: We identified trials of varying quality that examined six different drug classes for treatment of delirium in critically ill adults. We found evidence that the alpha(2) agonist dexmedetomidine may shorten delirium duration, although this small effect (compared with placebo) was seen in pairwise analyses based on a single study and was not seen in the NMA results. Alpha(2) agonists also ranked best for duration of mechanical ventilation and length of ICU stay, whereas the CHE inhibitor rivastigmine was associated with longer ICU stay. We found no evidence of a difference between placebo and any drug in terms of delirium-free and coma-free days, days with coma, physical restraint use, length of stay, long-term cognitive outcomes, or mortality. No studies reported delirium relapse, resolution of symptoms, or quality of life. The ten ongoing studies and the six studies awaiting classification that we identified, once published and assessed, may alter the conclusions of the review.
Loading...
6,253 / 5,000
Loading...

Translation results

Translating...
Translations are gender-specific. Learn more
Some sentences may contain gender-specific alternatives. Click a sentence to see alternatives. Learn more
Translation error
Send feedback

Document translation

Detect language
French
Translate from
Detect language
All languages
Afrikaans
Albanian
Amharic
Arabic
Armenian
Assamese
Aymara
Azerbaijani
Bambara
Basque
Belarusian
Bengali
Bhojpuri
Bosnian
Bulgarian
Catalan
Cebuano
Chichewa
Chinese (Simplified)
Chinese (Traditional)
Corsican
Croatian
Czech
Danish
Dhivehi
Dogri
Dutch
English
Esperanto
Estonian
Ewe
Filipino
Finnish
French
Frisian
Galician
Georgian
German
Greek
Guarani
Gujarati
Haitian Creole
Hausa
Hawaiian
Hebrew
Hindi
Hmong
Hungarian
Icelandic
Igbo
Ilocano
Indonesian
Irish
Italian
Japanese
Javanese
Kannada
Kazakh
Khmer
Kinyarwanda
Konkani
Korean
Krio
Kurdish (Kurmanji)
Kurdish (Sorani)
Kyrgyz
Lao
Latin
Latvian
Lingala
Lithuanian
Luganda
Luxembourgish
Macedonian
Maithili
Malagasy
Malay
Malayalam
Maltese
Maori
Marathi
Meiteilon (Manipuri)
Mizo
Mongolian
Myanmar (Burmese)
Nepali
Norwegian
Odia (Oriya)
Oromo
Pashto
Persian
Polish
Portuguese
Punjabi
Quechua
Romanian
Russian
Samoan
Sanskrit
Scots Gaelic
Sepedi
Serbian
Sesotho
Shona
Sindhi
Sinhala
Slovak
Slovenian
Somali
Spanish
Sundanese
Swahili
Swedish
Tajik
Tamil
Tatar
Telugu
Thai
Tigrinya
Tsonga
Turkish
Turkmen
Twi
Ukrainian
Urdu
Uyghur
Uzbek
Vietnamese
Welsh
Xhosa
Yiddish
Yoruba
Zulu
Translate to
All languages
Afrikaans
Albanian
Amharic
Arabic
Armenian
Assamese
Aymara
Azerbaijani
Bambara
Basque
Belarusian
Bengali
Bhojpuri
Bosnian
Bulgarian
Catalan
Cebuano
Chichewa
Chinese (Simplified)
Chinese (Traditional)
Corsican
Croatian
Czech
Danish
Dhivehi
Dogri
Dutch
English
Esperanto
Estonian
Ewe
Filipino
Finnish
French
Frisian
Galician
Georgian
German
Greek
Guarani
Gujarati
Haitian Creole
Hausa
Hawaiian
Hebrew
Hindi
Hmong
Hungarian
Icelandic
Igbo
Ilocano
Indonesian
Irish
Italian
Japanese
Javanese
Kannada
Kazakh
Khmer
Kinyarwanda
Konkani
Korean
Krio
Kurdish (Kurmanji)
Kurdish (Sorani)
Kyrgyz
Lao
Latin
Latvian
Lingala
Lithuanian
Luganda
Luxembourgish
Macedonian
Maithili
Malagasy
Malay
Malayalam
Maltese
Maori
Marathi
Meiteilon (Manipuri)
Mizo
Mongolian
Myanmar (Burmese)
Nepali
Norwegian
Odia (Oriya)
Oromo
Pashto
Persian
Polish
Portuguese
Punjabi
Quechua
Romanian
Russian
Samoan
Sanskrit
Scots Gaelic
Sepedi
Serbian
Sesotho
Shona
Sindhi
Sinhala
Slovak
Slovenian
Somali
Spanish
Sundanese
Swahili
Swedish
Tajik
Tamil
Tatar
Telugu
Thai
Tigrinya
Tsonga
Turkish
Turkmen
Twi
Ukrainian
Urdu
Uyghur
Uzbek
Vietnamese
Welsh
Xhosa
Yiddish
Yoruba
Zulu

Drag and drop

Or choose a file
Supported file types: .docx, .pdf, .pptx, .xlsx. Learn more
Drop file here
Send feedback

Website translation

Detect language
French
Translate from
Detect language
All languages
Afrikaans
Albanian
Amharic
Arabic
Armenian
Assamese
Aymara
Azerbaijani
Bambara
Basque
Belarusian
Bengali
Bhojpuri
Bosnian
Bulgarian
Catalan
Cebuano
Chichewa
Chinese (Simplified)
Chinese (Traditional)
Corsican
Croatian
Czech
Danish
Dhivehi
Dogri
Dutch
English
Esperanto
Estonian
Ewe
Filipino
Finnish
French
Frisian
Galician
Georgian
German
Greek
Guarani
Gujarati
Haitian Creole
Hausa
Hawaiian
Hebrew
Hindi
Hmong
Hungarian
Icelandic
Igbo
Ilocano
Indonesian
Irish
Italian
Japanese
Javanese
Kannada
Kazakh
Khmer
Kinyarwanda
Konkani
Korean
Krio
Kurdish (Kurmanji)
Kurdish (Sorani)
Kyrgyz
Lao
Latin
Latvian
Lingala
Lithuanian
Luganda
Luxembourgish
Macedonian
Maithili
Malagasy
Malay
Malayalam
Maltese
Maori
Marathi
Meiteilon (Manipuri)
Mizo
Mongolian
Myanmar (Burmese)
Nepali
Norwegian
Odia (Oriya)
Oromo
Pashto
Persian
Polish
Portuguese
Punjabi
Quechua
Romanian
Russian
Samoan
Sanskrit
Scots Gaelic
Sepedi
Serbian
Sesotho
Shona
Sindhi
Sinhala
Slovak
Slovenian
Somali
Spanish
Sundanese
Swahili
Swedish
Tajik
Tamil
Tatar
Telugu
Thai
Tigrinya
Tsonga
Turkish
Turkmen
Twi
Ukrainian
Urdu
Uyghur
Uzbek
Vietnamese
Welsh
Xhosa
Yiddish
Yoruba
Zulu
Translate to
All languages
Afrikaans
Albanian
Amharic
Arabic
Armenian
Assamese
Aymara
Azerbaijani
Bambara
Basque
Belarusian
Bengali
Bhojpuri
Bosnian
Bulgarian
Catalan
Cebuano
Chichewa
Chinese (Simplified)
Chinese (Traditional)
Corsican
Croatian
Czech
Danish
Dhivehi
Dogri
Dutch
English
Esperanto
Estonian
Ewe
Filipino
Finnish
French
Frisian
Galician
Georgian
German
Greek
Guarani
Gujarati
Haitian Creole
Hausa
Hawaiian
Hebrew
Hindi
Hmong
Hungarian
Icelandic
Igbo
Ilocano
Indonesian
Irish
Italian
Japanese
Javanese
Kannada
Kazakh
Khmer
Kinyarwanda
Konkani
Korean
Krio
Kurdish (Kurmanji)
Kurdish (Sorani)
Kyrgyz
Lao
Latin
Latvian
Lingala
Lithuanian
Luganda
Luxembourgish
Macedonian
Maithili
Malagasy
Malay
Malayalam
Maltese
Maori
Marathi
Meiteilon (Manipuri)
Mizo
Mongolian
Myanmar (Burmese)
Nepali
Norwegian
Odia (Oriya)
Oromo
Pashto
Persian
Polish
Portuguese
Punjabi
Quechua
Romanian
Russian
Samoan
Sanskrit
Scots Gaelic
Sepedi
Serbian
Sesotho
Shona
Sindhi
Sinhala
Slovak
Slovenian
Somali
Spanish
Sundanese
Swahili
Swedish
Tajik
Tamil
Tatar
Telugu
Thai
Tigrinya
Tsonga
Turkish
Turkmen
Twi
Ukrainian
Urdu
Uyghur
Uzbek
Vietnamese
Welsh
Xhosa
Yiddish
Yoruba
Zulu
Translating
Send feedback

Image translation

Detect language
French
Translate from
Detect language
All languages
Afrikaans
Albanian
Amharic
Arabic
Armenian
Assamese
Aymara
Azerbaijani
Bambara
Basque
Belarusian
Bengali
Bhojpuri
Bosnian
Bulgarian
Catalan
Cebuano
Chichewa
Chinese (Simplified)
Chinese (Traditional)
Corsican
Croatian
Czech
Danish
Dhivehi
Dogri
Dutch
English
Esperanto
Estonian
Ewe
Filipino
Finnish
French
Frisian
Galician
Georgian
German
Greek
Guarani
Gujarati
Haitian Creole
Hausa
Hawaiian
Hebrew
Hindi
Hmong
Hungarian
Icelandic
Igbo
Ilocano
Indonesian
Irish
Italian
Japanese
Javanese
Kannada
Kazakh
Khmer
Kinyarwanda
Konkani
Korean
Krio
Kurdish (Kurmanji)
Kurdish (Sorani)
Kyrgyz
Lao
Latin
Latvian
Lingala
Lithuanian
Luganda
Luxembourgish
Macedonian
Maithili
Malagasy
Malay
Malayalam
Maltese
Maori
Marathi
Meiteilon (Manipuri)
Mizo
Mongolian
Myanmar (Burmese)
Nepali
Norwegian
Odia (Oriya)
Oromo
Pashto
Persian
Polish
Portuguese
Punjabi
Quechua
Romanian
Russian
Samoan
Sanskrit
Scots Gaelic
Sepedi
Serbian
Sesotho
Shona
Sindhi
Sinhala
Slovak
Slovenian
Somali
Spanish
Sundanese
Swahili
Swedish
Tajik
Tamil
Tatar
Telugu
Thai
Tigrinya
Tsonga
Turkish
Turkmen
Twi
Ukrainian
Urdu
Uyghur
Uzbek
Vietnamese
Welsh
Xhosa
Yiddish
Yoruba
Zulu
Translate to
All languages
Afrikaans
Albanian
Amharic
Arabic
Armenian
Assamese
Aymara
Azerbaijani
Bambara
Basque
Belarusian
Bengali
Bhojpuri
Bosnian
Bulgarian
Catalan
Cebuano
Chichewa
Chinese (Simplified)
Chinese (Traditional)
Corsican
Croatian
Czech
Danish
Dhivehi
Dogri
Dutch
English
Esperanto
Estonian
Ewe
Filipino
Finnish
French
Frisian
Galician
Georgian
German
Greek
Guarani
Gujarati
Haitian Creole
Hausa
Hawaiian
Hebrew
Hindi
Hmong
Hungarian
Icelandic
Igbo
Ilocano
Indonesian
Irish
Italian
Japanese
Javanese
Kannada
Kazakh
Khmer
Kinyarwanda
Konkani
Korean
Krio
Kurdish (Kurmanji)
Kurdish (Sorani)
Kyrgyz
Lao
Latin
Latvian
Lingala
Lithuanian
Luganda
Luxembourgish
Macedonian
Maithili
Malagasy
Malay
Malayalam
Maltese
Maori
Marathi
Meiteilon (Manipuri)
Mizo
Mongolian
Myanmar (Burmese)
Nepali
Norwegian
Odia (Oriya)
Oromo
Pashto
Persian
Polish
Portuguese
Punjabi
Quechua
Romanian
Russian
Samoan
Sanskrit
Scots Gaelic
Sepedi
Serbian
Sesotho
Shona
Sindhi
Sinhala
Slovak
Slovenian
Somali
Spanish
Sundanese
Swahili
Swedish
Tajik
Tamil
Tatar
Telugu
Thai
Tigrinya
Tsonga
Turkish
Turkmen
Twi
Ukrainian
Urdu
Uyghur
Uzbek
Vietnamese
Welsh
Xhosa
Yiddish
Yoruba
Zulu

Drag and drop

Or choose a file
Supported file types: .jpg, .jpeg, .png. Learn more
Drop file here
Send feedback
5,000 character limit. Use the arrows to translate more.

Saved

History

Google apps
Main menu